Online inquiry

IVTScrip™ mRNA-Human ANKZF1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21542MR)

This product GTTS-WK21542MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKZF1 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001042410.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 55139
UniProt ID Q9H8Y5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKZF1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21542MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25614MR IVTScrip™ mRNA-Human ARHGEF26, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF26
GTTS-WK26602MR IVTScrip™ mRNA-Human ASCC1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ASCC1
GTTS-WK24369MR IVTScrip™ mRNA-Human ARFGAP1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARFGAP1
GTTS-WK19703MR IVTScrip™ mRNA-Human ANKRD17, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD17
GTTS-WK13371MR IVTScrip™ mRNA-Human ACTR2, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ACTR2
GTTS-WK26558MR IVTScrip™ mRNA-Human ARMC9, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARMC9
GTTS-WK27998MR IVTScrip™ mRNA-Human ARHGAP39, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARHGAP39
GTTS-WK25946MR IVTScrip™ mRNA-Human ARL6, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARL6
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →